Absci
Price & Volume
Stats
See more52W Range | $2.24-$12.05 |
Market Cap | $1.4B |
Shares Short | 37M |
Financials
See moreRevenue (12 Mos) | $1.5M |
Revenue Growth (YoY) | -46.4% |
Gross Profit (12 Mos) | -$84.2M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 7 days ago
Biotech Breakout: What's in focus after Moderna's cancer win?
Yahoo Finance • 19 days ago
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation
Yahoo Finance • 19 days ago
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?
Yahoo Finance • 20 days ago
Absci anticipates ABS-201 interim proof of concept data in 2H 2026, while guiding cash runway into 2H 2028
About
CEO | Mr. Sean McClain |
CFO | Dr. Zachariah Jonasson Ph.D. |
Address | 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 140 |